Palmitate activates insulin signaling pathway in pancreatic rat islets

Pancreas

Volumn 38, Issue 5, 2009, Pages 578-584

  Graciano, Maria Fernanda R ^a   Nogueira, Tatiane C A ^a   Carvalho, Carla R O ^a   Curi, Rui ^a   Carpinelli, Angelo R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ERK1 2; Insulin receptor signaling; IRS2; Palmitate; Pancreatic islets; STAT3

Indexed keywords

CASPASE 3; GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; SERINE; STAT3 PROTEIN; THREONINE; TYROSINE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INCUBATION TIME; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CASPASE 3; CELL LINE; FEMALE; GLUCOSE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; ISLETS OF LANGERHANS; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PALMITATES; PHOSPHORYLATION; RATS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 67651100672     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31819e65d1     Document Type: Article

References (39)

1. Crespin SR, Greenough WB, Steinberg D. Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. J Clin Invest. 1973;52:1979-1984.
2. Warnotte C, Gilon P, Nenquin M, et al. Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes. 1994;43:703-711.
3. Carpinelli AR, Picinato MC, Stevanato E, et al. Insulin secretion induced by palmitate - a process fully dependent on glucose concentration. Diabetes Metab. 2002;28:3S37-S44; discussion 3S108-12.
4. Wang Y, Wang PY, Takashi K. Chronic effects of different non-esterified fatty acids on pancreatic islets of rats. Endocrine. 2006;29:169-173.
5. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest. 1994;93:870-876.
6. Prentki M, Corkey BE. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes. 1996;45:273-283.
7. Martins EF, Miyasaka CK, Newsholme P, et al. Changes of fatty acid composition in incubated rat pancreatic islets. Diabetes Metab. 2004;30:21-27.
8. Aspinwall CA, Qian WJ, Roper MG, et al. Roles of insulin receptor substrate-1, phosphatidylinositol 3-kinase, and release of intracellular Ca2+ stores in insulin-stimulated insulin secretion in beta-cells. J Biol Chem. 2000;275:22331-22338.
9. Khan FA, Goforth PB, Zhang M, et al. Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinaseYdependent pathway. Diabetes. 2001;50:2192-2198.
10. Withers DJ, Burks DJ, Towery HH, et al. IRS-2 coordinates Igf-1 receptorYmediated beta-cell development and peripheral insulin signalling. Nat Genet. 1999;23:32-40.
11. Kubota N, Tobe K, Terauchi Y, et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes. 2000;49: 1880-1889.
12. Leibiger IB, Leibiger B, Moede T, et al. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell. 1998;1:933-938.
13. Mohanty S, Spinas GA, Maedler K, et al. Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Exp Cell Res. 2005;303:68-78.
14. Blandino-Rosano M, Perez-Arana G, Mellado-Gil JM, et al. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1. J Mol Endocrinol. 2008;41:35-44.
15. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415-1421.
16. Tsukiyama S, Matsushita M, Matsumoto S, et al. Transduction of exogenous constitutively activated Stat3 into dispersed islets induces proliferation of rat pancreatic beta-cells. Tissue Eng. 2006;12: 131-140.
17. Tanabe K, Okuya S, Tanizawa Y, et al. Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogen-activated protein kinase. Biochem Biophys Res Commun. 1997;241:765-768.
18. Haber EP, Hirabara SM, Gomes AD, et al. Palmitate modulates the early steps of insulin signalling pathway in pancreatic islets. FEBS Lett. 2003;544:185-188.
19. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967;16:35-39.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
21. Andersson M, Sjostrand J, Petersen A, et al. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:2623-2632.
22. Lingohr MK, Dickson LM, McCuaig JF, et al. Activation of IRS-2Ymediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes. 2002;51: 966-976.
23. Rhodes CJ, White MF. Molecular insights into insulin action and secretion. Eur J Clin Invest. 2002;32(suppl 3):3-13.
24. Simon MN, Azevedo-Martins AK, Amanso AM, et al. Persistent activation of Akt or ERK prevents the toxicity induced by saturated and polyunsaturated fatty acids in RINm5F beta-cells. Toxicol In Vitro. 2008;22:1018-1024.
25. Pearson LL, Castle BE, Kehry MR. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptorYassociated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways. Int Immunol. 2001;13:273-283.
26. Brunet A, Roux D, Lenormand P, et al. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factorYinduced gene expression and cell cycle entry. EMBO J. 1999; 18:664-674.
27. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995;270:14843-14846.
28. Costes S, Broca C, Bertrand G, et al. ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes. 2006;55:2220-2230.
29. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82:241-250.
30. Chung J, Uchida E, Grammer TC, et al. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol. 1997;17:6508-6516.
31. Lim CP, Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem. 1999;274:31055-31061.
32. Lo RK, Cheung H, Wong YH. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism. J Biol Chem. 2003;278:52154- 52165.
33. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000;12:186-192.
34. Saxena M, Mustelin T. Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin Immunol. 2000;12:387-396.
35. Fukada T, Ohtani T, Yoshida Y, et al. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J. 1998;17:6670-6677.
36. Shirogane T, Fukada T, Muller JM, et al. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity. 1999;11:709-719.
37. Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10:105-115.
38. Gorogawa S, Fujitani Y, Kaneto H, et al. Insulin secretory defects and impaired islet architecture in pancreatic beta-cellYspecific STAT3 knockout mice. Biochem Biophys Res Commun. 2004;319:1159-1170.
39. Abaraviciene SM, Lundquist I, Salehi A. Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities. Cell Mol Life Sci. 2008;65:2256-2265.